The pharmaceutical industry is witnessing a paradigm shift in drug formulation techniques, driven by the quest for enhancing drug efficacy and patient outcomes. One of the critical aspects of this evolution is the focus on bioavailability analysis. Bioavailability, the extent and rate at which a drug enters systemic circulation, plays a pivotal role in determining its therapeutic effectiveness. Recent advancements in bioavailability analysis methodologies have not only enabled a deeper understanding of drug absorption kinetics but also paved the way for the development of more efficient and patient-friendly formulations. This article explores the key innovations in bioavailability analysis and their implications for drug formulation revolution. Before delving into advancements, it's crucial to grasp the concept of bioavailability. When a drug is administered, it undergoes various processes such as dissolution, absorption, metabolism and excretion. Bioavailability refers to the fraction of the administered dose that reaches systemic circulation unchanged and the rate at which it reaches the target site. Factors such as drug formulation, route of administration and patient-specific variables influence bioavailability.
HTML PDFShare this article
Journal of Formulation Science & Bioavailability received 23 citations as per Google Scholar report
